Phase I results of a multicenter, open-label, dose de-escalation and expansion study of gemcitabine and cisplatin with ivosidenib or pemigatinib for advanced cholangiocarcinoma

Investigational New Drugs 2026

View at publisher
Authors: Fen Saj, Tanios S. Bekaii-Saab, Milind Javle, Joseph J. Larson, Mitesh J. Borad, S. Pant
DOI: 10.1007/s10637-026-01602-6
Cited by: 1
References: 16

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Fibroblast Growth Factor Research Pancreatic and Hepatic Oncology Research

Publication details

Journal / source
Investigational New Drugs
Publisher
Springer Science and Business Media LLC
Volume
44
Issue
1
Pages
48–55
Publication date
1 February 2026
Language
EN